Dietary Omega Polyunsaturated Fatty Acid Intake and Patient-Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program

被引:27
|
作者
Charoenwoodhipong, Prae [1 ]
Harlow, Sioban D. [1 ]
Marder, Wendy [1 ]
Hassett, Afton L. [1 ]
McCune, W. Joseph [1 ]
Gordon, Caroline [2 ]
Helmick, Charles G. [3 ]
Barbour, Kamil E. [3 ]
Wang, Lu [1 ]
Mancuso, Peter [1 ]
Somers, Emily C. [1 ]
Zick, Suzanna M. [1 ]
机构
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Univ Birmingham, Birmingham, W Midlands, England
[3] Ctr Dis Control & Prevent, Atlanta, GA USA
关键词
DISEASE-ACTIVITY; SLEEP; SUPPLEMENTATION; FIBROMYALGIA; VALIDATION; PROTECTINS; RESOLVINS; CRITERIA; QUALITY; TRIAL;
D O I
10.1002/acr.23925
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To examine associations between dietary intake of omega-3 (n-3; generally antiinflammatory) and omega-6 (n-6; generally proinflammatory) fatty acids and patient-reported outcomes in systemic lupus erythematosus (SLE). Methods This study was based on the population-based Michigan Lupus Epidemiology and Surveillance cohort. Estimates of n-3 and n-6 intake were derived from Diet History Questionnaire II items (past year with portion size version). Patient-reported outcomes included self-reported lupus activity (Systemic Lupus Activity Questionnaire [SLAQ]). Multivariable regression, adjusted for age, sex, race, and body mass index, was used to assess associations between absolute intake of n-3 and n-6, as well as the n-6:n-3 ratio, and patient-reported outcomes. Results Among 456 SLE cases, 425 (93.2%) were female, 207 (45.4%) were African American, and the mean +/- SD age was 52.9 +/- 12.3 years. Controlling for potential confounders, the average SLAQ score was significantly higher by 0.3 points (95% confidence interval [95% CI] 0.1, 0.6;P= 0.013) with each unit increase of the n-6:n-3 ratio. Both lupus activity and Patient-Reported Outcomes Measurement Information System (PROMIS) sleep disturbance scores were lower with each 1-gram/1,000 kcal increase of n-3 fatty acids (SLAQ regression coefficient beta = -0.8 [95% CI -1.6, 0.0];P= 0.055; PROMIS sleep beta = -1.1 [95% CI -2.0, -0.2];P= 0.017). Higher n-3 intakes were nonsignificantly associated with lower levels of depressive symptoms and comorbid fibromyalgia, and with higher quality of life, whereas results for the n6:n3 ratio trended in the opposite direction. Conclusion This population-based study suggests that higher dietary intake of n-3 fatty acids and lower n-6:n-3 ratios are favorably associated with patient-reported outcomes in SLE, particularly self-reported lupus activity and sleep quality.
引用
收藏
页码:874 / 881
页数:8
相关论文
共 50 条
  • [31] Patient-reported fatigue and its impact on patients with systemic lupus erythematosus
    Sterling, K. L.
    Gallop, K.
    Swinburn, P.
    Flood, E.
    French, A.
    Al Sawah, S.
    Iikuni, N.
    Naegeli, A. N.
    Nixon, A.
    LUPUS, 2014, 23 (02) : 124 - 132
  • [32] Association of Limited Health Literacy With Clinical and Patient-Reported Outcomes in Individuals With Systemic Lupus Erythematosus
    Maheswaranathan, Mithu
    Boan, Andrea D.
    Ramakrishnan, Viswanathan
    Johnson, Hetlena
    Rose, Jillian
    Dismuke-Greer, Clara L.
    Oates, Jim C.
    Egede, Leonard E.
    Williams, Edith
    ACR OPEN RHEUMATOLOGY, 2024, 6 (11) : 780 - 789
  • [33] Patient-reported outcomes and healthcare resource utilization in systemic lupus erythematosus: impact of disease activity
    Touma, Zahi
    Costenbader, Karen H.
    Hoskin, Ben
    Atkinson, Christian
    Bell, David
    Pike, James
    Berry, Pamela
    Karyekar, Chetan S.
    BMC RHEUMATOLOGY, 2024, 8 (01)
  • [34] Patient-Reported Disease Activity and Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus and Rheumatoid Arthritis
    Harris, Nathaniel
    Eudy, Amanda M.
    Clowse, Megan E. B.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [35] Fighting Fatigue in Systemic Lupus Erythematosus: Experience of Dehydroepiandrosterone on Clinical Parameters and Patient-Reported Outcomes
    Skoglund, Oliver
    Walhelm, Tomas
    Thyberg, Ingrid
    Eriksson, Per
    Sjowall, Christopher
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (18)
  • [36] Patient-Reported Disease Activity and Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus and Rheumatoid Arthritis
    Harris, Nathaniel
    Eudy, Amanda
    Clowse, Megan
    ARTHRITIS CARE & RESEARCH, 2019, 71 (03) : 390 - 397
  • [37] The Impact of Limited Health Literacy on Patient-Reported Outcomes (PROs) in Systemic Lupus Erythematosus (SLE)
    Katz, Patricia P.
    Dall'Era, Maria
    Trupin, Laura
    Lanata, Cristina
    Rush, Stephanie
    Helmick, Charles G.
    Criswell, Lindsey A.
    Yazdany, Jinoos
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [38] Patient experience in systemic lupus erythematosus: Development of novel patient-reported symptom and patient-reported impact measures
    Mathias S.D.
    Berry P.
    De Vries J.
    Pascoe K.
    Colwell H.H.
    Chang D.J.
    Askanase A.D.
    Journal of Patient-Reported Outcomes, 2 (1)
  • [39] Economic insecurities and patient-reported outcomes in patients with systemic lupus erythematosus in the USA : a cross-sectional analysis of data from the California Lupus Epidemiology Study
    Sandoval-Heglund, Donavon
    Roberts, Eric
    Park, Joonsuk
    Dall'Era, Maria
    Lanata, Cristina
    Barbour, Kamil E.
    Greenlund, Kurt J.
    Gordon, Caroline
    Katz, Patricia P.
    Yazdany, Jinoos
    LANCET RHEUMATOLOGY, 2024, 6 (02): : e105 - e114
  • [40] A systematic review of patient-reported outcomes in patients with cutaneous lupus erythematosus
    Ogunsanya, M. E.
    Kalb, S. J.
    Kabaria, A.
    Chen, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (01) : 52 - 61